EPH receptor/ephrin system: in the quest for novel anti‐angiogenic therapies: Commentary on Hassan‐Mohamed et al., Br J Pharmacol 171: 5195–5208

Linked Article

This article is a Commentary on Hassan‐Mohamed I, Giorgio C, Incerti M, Russo S, Pala D, Pasquale EB, Zanotti I, Vicini P, Barocelli E, Rivara S, Mor M, Lodola A and Tognolini M (2014). UniPR129 is a competitive small molecule Eph‐ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. Br J Pharmacol 171: 5195–5208. doi: 10.1111/bph.12669

DOI: 10.1111/bph.12718

View this article

• Full article (html)
• Enhanced article (html)
• PDF
• References